15 Jun 2023

Positive results of recertificate audit ISO 27001
On 14 June 2023, we had the pleasure of being audited by TÜV NORD Polska Sp. z o.o. as part of the 1st surveillance audit conducted in accordance with PN-EN ISO/IEC 27001:2017. Completed successfully with no non-conformities, the audit maintains the validity of the certificate issued in 2022 ISO 27001 certification refers to the international standard for information security management. It is one of the most recognised and widely used standards in the area of information security management. Surveillance audits are an important part of the ISO 27001 certification process to verify by the certification body that the organisation continues to meet the requirements of the ISO 27001 standard and maintains an effective Information Security Management System.

31 May 2023

Key highlights from Nestmedic’s 2022 Annual Report
Discover the key highlights from Nestmedic’s 2022 Annual Report: Completed Series M share subscription, securing an additional capital of 9,920,000 PLN. This allowed us to expand our team and boost our commercial activities. Our focus remained on finalizing the development of Pregnabit®, with a strong emphasis on obtaining the necessary certifications for our products and swiftly entering the market. Nestmedic proudly became the world’s first company to achieve MDR certification for our Pregnabit Pro device and Pregnabit Cloud Platform for mobile CTG. This certification, issued by TÜV Rheinland LGA Products GmbH in Q2 2022, demonstrates our unwavering commitment to meeting the highest quality and safety standards. We experienced a 185% sales growth compared to the previous year, reflecting the growing demand for our innovative solutions. A big thank you to our great team, partners and customers for their continued support. Together, we will continue to make a positive impact on the healthcare industry!

16 May 2023

Cooperation with Polish-French Chamber of Commerce
We have established cooperation with the French-Polish Chamber of Commerce due to the fact that the French market has great potential for telemedicine solutions. This cooperation will allow us to commercialize our solution in the French market on a larger scale. At the moment, we have already deployed 18 of our Pregnabit Pro devices in France